Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
symbicort
bb farma s.r.l. - formoterolo e budesonide - formoterolo e budesonide
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension
astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - bpco - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 1 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 1 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 0.5 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 0.5 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
budenofalk 3 mg capsule
dr. falk pharma ag - budesonidum - capsule - budesonidum 3 mg, sacchari sphaerae corresp. saccharum 276 mg et maydis amylum, lactosum monohydricum 12 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 127, e 172 (nigrum), natrii laurilsulfas corresp. natrium 0.006 mg, pro capsula. - morbus chron, kollagene colitis - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
cortinasal 50 nasenspray, suspension
spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 50 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
cortinasal 100 nasenspray, suspension
spirig healthcare ag - budesonidum - nasenspray, suspension - budesonidum 100 µg, glucosum, cellulosum microcristallinum et carmellosum natricum, e 202 60 µg, polysorbatum 80, dinatrii edetas, acidum hydrochloridum, aqua purificata ad suspensionem pro dosi. doses pro vase 200. - la rinite - synthetika
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
entocort enema clistere
tillotts pharma ag - budesonidum - clistere - i) dispergierbare tablette: budesonidum 2.3 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas pro compresso. ii) vehikel: e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad solutionem pro 100 ml. suspensio reconstituta: budesonidum 2 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad suspensionem pro 100 ml. - la colite ulcerosa - synthetika
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
reticus loz 30g 0,05%
sinclair srl - desonide - lozione - "0,05% soluzione cutanea" flacone 30 g
Suiza -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
budenofalk uno 9 mg magensaftresistentes granulat
dr. falk pharma ag - budesonidum - magensaftresistentes granulat - budesonidum 9 mg, sacchari sphaerae corresp. saccharum 828 mg, lactosum monohydricum 36 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, aromatica zitrone cum citralum et citronellolum et limonenum et geraniolum et linaloolum, xanthani gummi, sorbitolum 899.5 mg, acidum citricum, sucralosum, magnesii stearas, ad granulatum pro charta. - morbus crohn, kollagene colitis - synthetika